ArticleFrontiers in aging2025
Kefir and healthy aging: revealing thematic gaps through AI-assisted screening and semantic evidence mapping.
Article in Frontiers in aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kefir, fermented milk rich in probiotics, has attracted growing attention for its potential anti-aging effects. Yet, studies specifically addressing kefir in the context of aging remain limited and scattered across diverse biological fields. To overcome this fragmentation, we applied an integrative approach that combines a cutting-edge AI-assisted algorithm for evidence screening with a Python-based semantic clustering pipeline. This allowed us to systematically map and classify the existing literature into four functional domains of aging: changes in body composition, energy balance, homeostatic signaling networks, and neurodegeneration. The resulting evidence map revealed a marked thematic imbalance, with most studies concentrated in mechanistic pathways such as inflammation and oxidative stress, and far fewer addressing neurocognitive or metabolic outcomes. This asymmetry suggests a structural bias in current research priorities and highlights the need to expand kefir-related studies toward more clinically relevant aging endpoints. By merging AI with domain-specific linguistic tools, our study provides a reproducible and data-driven strategy to uncover thematic blind spots and guide future investigations into kefir's anti-aging potential.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.